Funding source in Global project
Year:

None

Check the details 3(18.75%)

Abbvie Pharmaceutical Trading (Shanghai) Co., Ltd.

Check the details 1(6.25%)

Beijing Municipal Administration of Hospitals

Check the details 1(6.25%)

Self-raised

Check the details 1(6.25%)

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support(XMLX202103)

Check the details 1(6.25%)

National Key Research and Development Program of China

Check the details 1(6.25%)

National Natural Science Foundation of China

Check the details 1(6.25%)

Self-financing

Check the details 1(6.25%)

National Nature Science Foundation of China

Check the details 1(6.25%)

The State Natural Science Fund projects: Anti-enteric neuronal antibody causes intestinal neuronal injury in achalasia of cardia and its predictive value for therapeutic effect (No. 81970476)

Check the details 1(6.25%)

Capital Health Development Research Special Project - First Launch 2024-2-5063

Check the details 1(6.25%)

Sponsor

Check the details 1(6.25%)

National level - National Natural Science Foundation of China: Anti intestinal neuron antibody induced intestinal neuron damage in achalasia of the cardia and its predictive value for therapeutic effect (81970476);

Check the details 1(6.25%)

Capital’s Funds for Health Improvement and Research

Check the details 1(6.25%)